Healthcare provider profile · identity verified

Arthur J Rillo, MD

Family Practice · GRANITE FALLS, MN · NPI 1619943404

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	427	93
Atorvastatin Calcium	Atorvastatin Calcium	426	102
Amlodipine Besylate	Amlodipine Besylate	414	97
Lisinopril	Lisinopril	401	94
Metoprolol Succinate	Metoprolol Succinate	345	77
Gabapentin	Gabapentin	321	62
Furosemide	Furosemide	312	58
Levothyroxine Sodium	Levothyroxine Sodium	303	68
Simvastatin	Simvastatin	287	66
Potassium Chloride	Potassium Chloride	252	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	236	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	219	42
Metoprolol Tartrate	Metoprolol Tartrate	210	47
Pantoprazole Sodium	Pantoprazole Sodium	207	40
Losartan Potassium	Losartan Potassium	206	56
Tramadol Hcl	Tramadol Hcl	200	39
Metformin Hcl Er	Metformin Hcl	183	51
Ozempic	Semaglutide	178	26
Tamsulosin Hcl	Tamsulosin Hcl	156	31
Metformin Hcl	Metformin Hcl	152	39
Hydrochlorothiazide	Hydrochlorothiazide	142	45
Citalopram Hbr	Citalopram Hydrobromide	141	24
Albuterol Sulfate Hfa	Albuterol Sulfate	132	39
Allopurinol	Allopurinol	128	34
Carvedilol	Carvedilol	123	21
Duloxetine Hcl	Duloxetine Hcl	123	18
Alendronate Sodium	Alendronate Sodium	122	37
Prednisone	Prednisone	122	72
Fluoxetine Hcl	Fluoxetine Hcl	106	24
Chlorthalidone	Chlorthalidone	103	28
Alprazolam	Alprazolam	101	22
Jantoven	Warfarin Sodium	96	18
Famotidine	Famotidine	87	18
Lorazepam	Lorazepam	81	18
Pravastatin Sodium	Pravastatin Sodium	80	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	15
Eliquis	Apixaban	76	18
Mirtazapine	Mirtazapine	76	suppressed
Xarelto	Rivaroxaban	73	15
Doxazosin Mesylate	Doxazosin Mesylate	72	19
Trazodone Hcl	Trazodone Hcl	70	19
Cephalexin	Cephalexin	69	59
Rosuvastatin Calcium	Rosuvastatin Calcium	65	20
Clopidogrel	Clopidogrel Bisulfate	62	19
Azithromycin	Azithromycin	60	51
Glimepiride	Glimepiride	58	14
Morphine Sulfate Er	Morphine Sulfate	58	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	57	14
Fluticasone Propionate	Fluticasone Propionate	55	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	41
Paroxetine Hcl	Paroxetine Hcl	52	12
Sertraline Hcl	Sertraline Hcl	52	17
Atenolol	Atenolol	51	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	22
Lantus	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Levetiracetam	Levetiracetam	51	suppressed
Buspirone Hcl	Buspirone Hcl	50	suppressed
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Bupropion Hcl Sr	Bupropion Hcl	48	suppressed
Pregabalin	Pregabalin	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Topiramate	Topiramate	43	suppressed
Meloxicam	Meloxicam	41	21
Metolazone	Metolazone	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Ezetimibe	Ezetimibe	38	11
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Spironolactone	Spironolactone	37	11
Hydromorphone Hcl	Hydromorphone Hcl	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Ventolin Hfa	Albuterol Sulfate	34	12
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Morphine Sulfate	Morphine Sulfate	31	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Jardiance	Empagliflozin	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	26	suppressed
Fentanyl	Fentanyl	26	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Levofloxacin	Levofloxacin	26	16
Amoxicillin	Amoxicillin	25	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Roflumilast	Roflumilast	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	16
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	25	suppressed
Nystatin	Nystatin	24	14
Acebutolol Hcl	Acebutolol Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Estradiol	Estradiol	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Novolog	Insulin Aspart	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	13
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Diazepam	Diazepam	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Budesonide Dr	Budesonide	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Etodolac	Etodolac	19	suppressed
Potassium Citrate Er	Potassium Citrate	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Cartia Xt	Diltiazem Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Linzess	Linaclotide	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Budesonide	Budesonide	13	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Dupixent Pen	Dupilumab	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Glipizide	Glipizide	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	11
Dilantin	Phenytoin Sodium Extended	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Methylphenidate Er (La)	Methylphenidate Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error